Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2071250058) titled 'A Phase 1 study to assess safety, tolerability and pharmacokinetics of single and multiple transdermal doses of SFG-02 in Japanese and white healthy adult subjects' on Aug. 5.
Study Type: Interventional
Study Design:
randomized controlled trial, double blind, placebo control, parallel assignment, other
Primary Sponsor: Tanaka Akira
Condition:
Healthy adult subjects
Healthy subjects
Intervention:
Transdermal formlation of SFG-02 or placebo is applied to abdomen skin single or repeated for 10 days
1) Part 1 (Japanese): single application once or twice
2) Part 2 (Japanese): repeated application for 10 day...